PRACTICE Registry

Principal Investigator: Dr Milan Gupta

Prospective Assessment of Cardiovascular risk and Treatment In Canadians of varying Ethnicity
AstraZeneca Investigator-Initiated Research Grant

2003-Ongoing

PRospective Assessment of Cardiovascular risk and Treatment In Canadians of varying Ethnicity

Status: Open to enrolment, ongoing patient follow-up

The PRACTICE Registry will assess the differences in biomarkers, risk factors and long term outcomes between South Asian and European Canadians with stable CHD.

Study Design: Observational

Intervention: N/A

Length of Study: Up to 10 years

Project Start: 2003

Project Completion: Ongoing

# of Patients: Over 600 (recruitment ongoing)

Patient Population: Patients with established Coronary Artery Disease

PRESENTATIONS: None available

PUBLICATIONS

Presented at the Canadian Cardiovascular Congress 2013, Scientific Session

Gupta, M., Kajil, M., Tsigoulis, M., Bansal A., Hirjikaka, S., Singh, N,. Verma, S. Adherence to evidence based medications in South Asian and White Caucasian patients with coronary heart disease: Insight from the PRACTICE Registry.Can J Cardiol. 2013; 29, Issue 10 (Suppl S): Page S275.

Presented at the Canadian Cardiovascular Congress 2011, Scientific Session

Gupta M, Tsigoulis M, Hirjikaka S, Kajil M, Mamdani M, Verma S. Comparative evaluation of adipokines, inflammatory markers and cardiovascular outcomes in Asian Indians vs. European whites with coronary heart disease: results from the PRACTICE registry.JACC. 2011; 57,14 (Suppl A): 95.

Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Tsigoulis M, Hirjikaka S, Kajil M, Mamdani M, Verma S. Cardiovascular outcomes in south Asians with coronary heart disease – Preliminary results from the PRACTICE Registry. Can J Cardiol. 2010;26(Suppl D):56D
View Poster »
View heart.org coverage at CCC 2010 »

Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Singh N, Teoh H, Yi Q, Strauss M, Tsigoulis M, Verma S. Fibrinolytic function in south Asians and Europeans with coronary heart disease: Insights from the PRACTICE Registry. Can J Cardiol. 2010;26(Suppl D):57D
View Poster »
View heart.org coverage at CCC 2010 »

Gupta M, Braga M. Prevalence and gender distribution of metabolic syndrome in South Asians and White Caucasians with coronary heart disease. Can J Cardiol 2007;23 (Suppl C):188C

Gupta M, Braga M, Gillett M, Desai N, Verma S. LDL response to statins does not differ between South Asians (SA) and white Caucasians (WC). Can J Cardiol. 2006; 22(Suppl D).

Gupta M, Evelegh M, Gillet J, Tse J. Skin tissue cholesterol and C-Reactive Protein are associated with metabolic syndrome in subjects with coronary heart disease. Can J Cardiol 2005;21(Suppl C):172C.

Gupta M, Tsigoulis M. Differences in traditional and novel risk factors in South Asians and Europeans with coronary disease despite similar use of evidence based treatments. Can J Cardiol 2004:20 (Suppl D): 129D.

Gupta M, Tsigoulis M. NCEP and WHO definitions are equally predictive of metabolic syndrome in South Asian but not European Canadians with coronary disease: Findings from the PRACTICE registry. Can J Cardiol 2004; 20 (Suppl D): 171D.

Gupta M, Tsigoulis M, Evelegh M. Skin tissue cholesterol is associated with angina, diabetes, and history of Stroke/TIA in subjects with coronary artery disease. Can J Cardiol 2004; 20(Suppl D):122D.

This study was funded by CCRN through an unrestricted investigator initiated research grant from AstraZeneca Canada Inc.

EDUCATIONAL PROGRAMS:


Learn More »

RESEARCH OPPORTUNITIES:


Learn More »

Learn More »


SANSAR

CCRN is partnering with SANSAR to provide community initiatives, implement research projects and support clinical services. Click below for more information

Learn More »